128 related articles for article (PubMed ID: 36396584)
21. [Long-term outcome of isolated local recurrence following radical nephrectomy].
Yang Y; Xiao YX; Zhou LQ; He ZS; Jin J
Beijing Da Xue Xue Bao Yi Xue Ban; 2014 Aug; 46(4):528-31. PubMed ID: 25131463
[TBL] [Abstract][Full Text] [Related]
22. Laparoscopic resection of local recurrence after previous radical nephrectomy for clinically localized renal-cell carcinoma: perioperative outcomes and initial observations.
Yohannan J; Feng T; Berkowitz J; Connolly SS; Pierorazio P; Allaf ME
J Endourol; 2010 Oct; 24(10):1609-12. PubMed ID: 20629564
[TBL] [Abstract][Full Text] [Related]
23. Oncological efficacy and safety of nephron-sparing surgery for selected patients with locally advanced renal cell carcinoma.
Margulis V; Tamboli P; Jacobsohn KM; Swanson DA; Wood CG
BJU Int; 2007 Dec; 100(6):1235-9. PubMed ID: 17979923
[TBL] [Abstract][Full Text] [Related]
24. Lack of retroperitoneal lymphadenopathy predicts survival of patients with metastatic renal cell carcinoma.
Vasselli JR; Yang JC; Linehan WM; White DE; Rosenberg SA; Walther MM
J Urol; 2001 Jul; 166(1):68-72. PubMed ID: 11435825
[TBL] [Abstract][Full Text] [Related]
25. Oncologic and Functional Outcomes of Radical and Partial Nephrectomy in pT3a Pathologically Upstaged Renal Cell Carcinoma: A Multi-institutional Analysis.
Patel SH; Uzzo RG; Larcher A; Peyronnet B; Lane BR; Pruthi D; Reddy M; Capitanio U; Joshi S; Noyes S; Eldefrawy A; Ghali F; Meagher MF; Hamilton ZA; Yim K; Nasseri R; Bradshaw AW; Dey S; Kirmiz S; Wan F; Liss MA; Bensalah K; Montorsi F; Derweesh IH
Clin Genitourin Cancer; 2020 Dec; 18(6):e723-e729. PubMed ID: 32600941
[TBL] [Abstract][Full Text] [Related]
26. [Local recurrence of renal cell carcinoma after nephrectomy].
Pereverzev AS; Shchukin DV; Iliukhin IuA
Urologiia; 2003; (6):14-8. PubMed ID: 14708237
[TBL] [Abstract][Full Text] [Related]
27. Simple enucleation versus radical nephrectomy in the treatment of pT1a and pT1b renal cell carcinoma.
Minervini A; Serni S; Tuccio A; Siena G; Vittori G; Masieri L; Giancane S; Lanciotti M; Khorrami S; Lapini A; Carini M
Ann Surg Oncol; 2012 Feb; 19(2):694-700. PubMed ID: 21861225
[TBL] [Abstract][Full Text] [Related]
28. Low Rate of Cancer Events After Partial Nephrectomy for Renal Cell Carcinoma: Clinicopathologic Analysis of 1994 Cases with Emphasis on Definition of "Recurrence".
Bertolo R; Nicolas M; Garisto J; Magi-Galluzzi C; McKenney JK; Kaouk J
Clin Genitourin Cancer; 2019 Jun; 17(3):209-215.e1. PubMed ID: 31000486
[TBL] [Abstract][Full Text] [Related]
29. Is Robotic Partial Nephrectomy Safe for T3a Renal Cell Carcinoma? Experience of a High-Volume Center.
Andrade HS; Zargar H; Akca O; Kara O; Caputo PA; Ramirez D; Andrés G; Stein RJ; Chueh SJ; Kaouk JH
J Endourol; 2017 Feb; 31(2):153-157. PubMed ID: 27881027
[TBL] [Abstract][Full Text] [Related]
30. Does the Unexpected Presence of Non-organ-confined Disease at Final Pathology Undermine Cancer Control in Patients with Clinical T1N0M0 Renal Cell Carcinoma Who Underwent Partial Nephrectomy?
Capitanio U; Stewart GD; Klatte T; Akdogan B; Roscigno M; Marszalek M; Dell'Oglio P; Zaffuto E; Rodriguez Faba O; Salagierski M; Lingard J; Carini M; Ouzaid I; Mir MC; Montorsi F; Da Pozzo LF; Stief C; Minervini A; Brookman-May SD
Eur Urol Focus; 2018 Dec; 4(6):972-977. PubMed ID: 28753867
[TBL] [Abstract][Full Text] [Related]
31. The operative safety and oncological outcomes of laparoscopic nephrectomy for T3 renal cell cancer.
Stewart GD; Ang WJ; Laird A; Tolley DA; Riddick AC; McNeill SA
BJU Int; 2012 Sep; 110(6):884-90. PubMed ID: 22289017
[TBL] [Abstract][Full Text] [Related]
32. Transperitoneal Robot-assisted Partial Nephrectomy with Minimum Follow-up of 5 Years: Oncological and Functional Outcomes from a Single Institution.
Bertolo R; Garisto J; Dagenais J; Sagalovich D; Stein R; Fareed K; Gao T; Armanyous S; Fergany A; Lioudis M; Kaouk J
Eur Urol Oncol; 2019 Mar; 2(2):207-213. PubMed ID: 31017098
[TBL] [Abstract][Full Text] [Related]
33. Five-year Oncologic Outcomes After Transperitoneal Robotic Partial Nephrectomy for Renal Cell Carcinoma.
Andrade HS; Zargar H; Caputo PA; Akca O; Kara O; Ramirez D; Haber GP; Stein RJ; Kaouk JH
Eur Urol; 2016 Jun; 69(6):1149-54. PubMed ID: 26719014
[TBL] [Abstract][Full Text] [Related]
34. Local and Regional Recurrences of Clinically Localized Renal Cell Carcinoma after Nephrectomy: A 15 Year Institutional Experience with Prognostic Features and Oncologic Outcomes.
Ray S; Cheaib JG; Biles MJ; Pineault KG; Johnson MH; Ged YMA; Markowski MC; Singla N; Allaf ME; Pierorazio PM
Urology; 2021 Aug; 154():201-207. PubMed ID: 33864855
[TBL] [Abstract][Full Text] [Related]
35. Radical Nephrectomy With or Without Lymph Node Dissection for Nonmetastatic Renal Cell Carcinoma: A Propensity Score-based Analysis.
Gershman B; Thompson RH; Moreira DM; Boorjian SA; Tollefson MK; Lohse CM; Costello BA; Cheville JC; Leibovich BC
Eur Urol; 2017 Apr; 71(4):560-567. PubMed ID: 27671144
[TBL] [Abstract][Full Text] [Related]
36. Positive Surgical Margins Increase Risk of Recurrence after Partial Nephrectomy for High Risk Renal Tumors.
Shah PH; Moreira DM; Okhunov Z; Patel VR; Chopra S; Razmaria AA; Alom M; George AK; Yaskiv O; Schwartz MJ; Desai M; Vira MA; Richstone L; Landman J; Shalhav AL; Gill I; Kavoussi LR
J Urol; 2016 Aug; 196(2):327-34. PubMed ID: 26907508
[TBL] [Abstract][Full Text] [Related]
37. Multiple ipsilateral renal tumors: retrospective analysis of surgical and oncological results of tumor enucleation vs radical nephrectomy.
Minervini A; Serni S; Giubilei G; Lanzi F; Vittori G; Lapini A; Carini M
Eur J Surg Oncol; 2009 May; 35(5):521-6. PubMed ID: 18640001
[TBL] [Abstract][Full Text] [Related]
38. Mortality Increases When Radical Nephrectomy is Delayed More Than 60 Days for T3 Renal Cell Carcinoma.
Zhao F; Liu X; Zhang C; Zhu H; Qi N
Technol Cancer Res Treat; 2021; 20():15330338211043963. PubMed ID: 34595976
[No Abstract] [Full Text] [Related]
39. Partial or radical nephrectomy for complex renal mass: a comparative analysis of oncological outcomes and complications from the ROSULA (Robotic Surgery for Large Renal Mass) Collaborative Group.
Cerrato C; Patel D; Autorino R; Simone G; Yang B; Uzzo R; Porpiglia F; Capitanio U; Porter J; Beksac AT; Minervini A; Antonelli A; Cerruto MA; Lau C; Ashrafi A; Eun D; Mottrie A; Mir C; Meagher MF; Puri D; Nguyen M; Dhanji S; Liu F; Pandolfo SD; Kutikov A; Montorsi F; Gill IS; Sundaram C; Kaouk J; Derweesh IH
World J Urol; 2023 Mar; 41(3):747-755. PubMed ID: 36856832
[TBL] [Abstract][Full Text] [Related]
40. Features associated with recurrence beyond 5 years after nephrectomy and nephron-sparing surgery for renal cell carcinoma: development and internal validation of a risk model (PRELANE score) to predict late recurrence based on a large multicenter database (CORONA/SATURN Project).
Brookman-May S; May M; Shariat SF; Xylinas E; Stief C; Zigeuner R; Chromecki T; Burger M; Wieland WF; Cindolo L; Schips L; De Cobelli O; Rocco B; De Nunzio C; Feciche B; Truss M; Gilfrich C; Pahernik S; Hohenfellner M; Zastrow S; Wirth MP; Novara G; Carini M; Minervini A; Simeone C; Antonelli A; Mirone V; Longo N; Simonato A; Carmignani G; Ficarra V;
Eur Urol; 2013 Sep; 64(3):472-7. PubMed ID: 22748912
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
